Season 1 · Episode 22
S1 Ep22: Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment
July 26, 202110m 42s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Elizabeth Yeu, MD, a cornea cataract and refractive surgeon at Virginia Eye Consultants shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of a new investigational therapeutic from Tarsus Pharmaceuticals called TP03 (lotilaner ophthalmic solution 0.25%), for the treatment of patients diagnosed with Demodex blepharitis.